Drawing for SYNBALANCE

USPTO serial 79356055

SYNBALANCE

Reviewed by CopyMark Law Group

Reg. 7198316Status 700Registered
Filing date
Status date
Registration date
Oct 24, 2023
Examiner
COLEMAN, CIMMERIAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNBALANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
040Manufacturing services for others in the field of probiotics and probiotic bacteria; Micro-encapsulating services for third parties; Custom manufacture of biopharmaceuticals and pharmaceutical products; Custom manufacture of products for pharmaceutical and/or food industries; Treatment, processing, finishing and preparation of active chemical ingredients, chemical formulations, chemical compounds, chemical compositions, chemicals, chemicals derived from botanical extracts, chemicals of plant origin, chemical additives, active chemical compounds, raw materials, semi-finished products, all the above products in the form of liquids, solutions, suspensions dispersions, solids, powders, soluble powders, or water-soluble powders for the preparation of pharmaceuticals, foods and dietary substances for medical or veterinary use, food for babies, food supplements for humans and animals, dietary supplements, nutraceuticals, foods for special medical purposes, functional foods and nutraceuticals used as dietary supplements; Custom manufacture of active chemical ingredients, chemical formulations, chemical compounds, chemicals derived from botanical extracts, chemicals of plant origin, chemical additives, active chemical compounds, raw materials, semi-finished products, active pharmaceutical ingredients and active substances, mineral salts, trace elements, carbohydrates, dietary fibres, vitamins, organic and/or inorganic acids and their salts, fatty acids, amino acids, proteins, peptides, antioxidants, phospholipids, oils, lipids, fats, flavourings, natural and synthetic extracts, microorganisms, enzymes, bacteria, yeasts and moulds, probiotic bacteria, prebiotic fibres, dairy chemicals, enzymes, coenzymes, Q10 coenzymes, yeasts, moulds, natural and synthetic pigments, natural and artificial sweeteners, sugars, food preservatives, all of the above used singly or in combination for the preparation and manufacture of pharmaceutical products, foods and dietary substances for medical or veterinary use, food for babies, food supplements for humans and animals, dietary supplements, nutraceuticals, foods for special medical purposes, functional foods and nutraceuticals used as dietary supplements, capsules or tablets for pharmaceutical products custom manufacture of active chemical ingredients, chemical formulations, chemical compounds, chemical compositions, chemicals, chemicals derived from botanical extracts, chemicals of plant origin, chemical additives, active chemical compounds, raw materials, semi-finished products, all the above products in the form of liquids, solutions, suspensions, dispersions, solids, powders, soluble powders, or water-soluble powders for the preparation of pharmaceuticals, foods and dietary substances for medical or veterinary use, food for babies, food supplements for humans and animals, dietary supplements, nutraceuticals, foods for special medical purposes, functional foods and nutraceuticals used as dietary supplements; Treatment, processing, finishing and preparation of chemical active ingredients, chemical formulations, chemical compositions, chemical compounds, chemicals, chemicals derived from botanical extracts, chemicals of plant origin, chemical additives, chemical active compounds, raw materials, semi-finished products, active pharmaceutical ingredients and active substances, mineral salts, trace elements, carbohydrates, dietary fibres, vitamins, organic and/or inorganic acids and their salts, fatty acids, amino acids, proteins, peptides, antioxidants, phospholipids, oils, lipids, fats, flavourings, natural and synthetic extracts, microorganisms, enzymes, bacteria, probiotic bacteria, prebiotic fibres, dairy chemicals, enzymes, coenzymes, Q10 coenzymes, yeasts, moulds, natural and synthetic colorings, natural and artificial sweeteners, sugars, food preservatives, all of the above used singly or in combination for the preparation and manufacture of pharmaceutical products, foods and dietetic substances for medical or veterinary use, food for babies, food supplements for humans and animals, dietary supplements, nutraceuticals, foods for special medical purposes, functional foods and nutraceuticals used as dietary supplements, capsules or tablets for pharmaceutical products custom manufacture of pharmaceuticals, foods and dietary substances for medical or veterinary use, food for babies, food supplements for humans and animals, dietary supplements, nutritional supplements, nutraceuticals, foods for special medical purposes, functional foods and nutraceuticals used as dietary supplements, capsules or tablets for pharmaceutical products; food processing, food processing for manufacturing processes; Microencapsulating services provided for others; Processing of biopharmaceutical materials on behalf of third parties; Custom manufacture of medical devices for others; Material assembly, namely, custom manufacturing of probiotics and probiotic bacteria for othersACTIVE
042Chemical laboratory services; Clinical studies and research in the field of dietary science or functional medicine; Research and development services in pharmaceutical, para-pharmaceutical, science, medicine, dietetics, nutrition, nutraceuticals, probiotics, prebiotics, symbiotics, biochemistry, chemistry, gynaecology, urology, gastroenterology, immunology, cardiovascular, dermatology, oral hygiene, osteoarticular and cosmetics; New product design services; Packaging design; Custom design of prototypes; Design and development of new technology for others in the field of dietary science or functional medicine; Design of packaging; Industrial design; Design of industrial products; Design and development of medical devices; Design and development of inhalers; Technological research in the field of inhalers; Technological research in the field of medical devices; Scientific research and development; Pharmaceutical research and development Research and development services in the field of biochemistry; Research and development services for the pharmaceutical industry; Research and development services in the field of biotechnology; Research and development of new products for others; Bacteriological research and development services; Research and development services in the field of microorganisms and cells; Consultancy relating to pharmaceutical research and development; Quality control on behalf of third parties; Product development on behalf of third parties; Cell culture services for scientific and research purposes on behalf of third partiesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
May 7, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 26, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 26, 2024FIMPFINAL DISPOSITION PROCESSED
Jan 24, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 24, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 8, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 19, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2023RFNTREFUSAL PROCESSED BY IB
Mar 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2023RFRRREFUSAL PROCESSED BY MPU
Feb 6, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 24, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 23, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2022DOCKASSIGNED TO EXAMINER
Nov 29, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance